A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study is a six-month, prospective, randomized, multicenter, single- blind, controlled
clinical study to evaluate the effect of three low-doses of Naturlose (Tagatose) on glycemic
control and safety in subjects with Type 2 diabetes under diet control and exercise. The
subjects were randomized in one of the 3 arms receiving 2.5, 5 or 7.5 gm of Tagatose.